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Thrombospondin repeat domains of proteins that function throughout the nervous system to guide axons. It had
previously been shown that Semaphorin 5A (Sema5A) was a bifunctional axon guidance cue for mammalian
midbrain neurons. We found that zebraﬁsh sema5A was expressed in myotomes during the period of motor
axon outgrowth. To determine whether Sema5A functioned in motor axon guidance, we knocked down
Sema5A, which resulted in two phenotypes: a delay in motor axon extension into the ventral myotome and
aberrant branching of these motor axons. Both phenotypes were rescued by injection of full-length rat
Sema5A mRNA. However, adding back RNA encoding the sema domain alone signiﬁcantly rescued the
branching phenotype in sema5A morphants. Conversely, adding back RNA encoding the thrombospondin
repeat (TSR) domain alone into sema5A morphants exclusively rescued delay in ventral motor axon
extension. Together, these data show that Sema5A is a bifunctional axon guidance cue for vertebrate motor
axons in vivo. The TSR domain promotes growth of developing motor axons into the ventral myotome
whereas the sema domain mediates repulsion and keeps these motor axons from branching into surrounding
myotome regions.
© 2008 Elsevier Inc. All rights reserved.Introduction
The establishment of neuromuscular speciﬁcity is an essential step
in nervous system development. Motor axon growth cones, like all
growth cones, respond to cues in the environment via receptors.
Biochemistry, genetic screens, and homology cloning have identiﬁed
major classes of axon guidance molecules such as netrins, semaphor-
ins, ephrins, slits and their receptors. Our understanding of the
speciﬁc molecules guiding motor axons to their targets has been
steadily increasing in recent years and some processes, such as
commissural axon guidance, have been very well characterized at the
molecular level. However, there are still some aspects, such as what
guides motor axon growth cones to their ultimate muscle target, that
have yet to be fully understood. To characterize motor axon guidance
cues both forward and reverse genetics have been taken using
zebraﬁsh as amodel system (see Beattie et al., 2000, 2002; Hutson and
Chien 2002; Schneider and Granato 2003). In this report we show that
the bifunctional molecule Semaphorin 5A (Sema5A) is a cue that
guides motor axons into the ventral myotome.
Due to its simplicity and visibility during development, the
zebraﬁsh motor axon network has been an excellent system for
elucidating guidance mechanisms. The three early developing spinal
cord primary motoneurons that innervate trunk axial muscle haveepartment of Pediatrics, The
l rights reserved.been useful for this purpose. In particular, Caudal Primary (CaP)
motoneurons that innervate the ventral axial muscle region have been
well studied due to their ease of visualization andmanipulation. Using
forward genetics, diwanka/lysyl hydroxlyase 3 was shown to be
necessary for guiding CaP, and the other early developing motoneur-
ons, along the initial part of their pathway by modifying the
extracellular matrix (ECM) in the region (Zeller and Granato 1999;
Schneider and Granato 2006). Unplugged/MuSK also acts early to
direct CaP to its correct path after reaching the ﬁrst intermediate
target presumably by also modifying the ECM (Zhang and Granato
2000; Zhang et al., 2004). Stumpy is needed for CaP axons and other
motor axons to extend past their intermediate targets and into distal
target regions (Beattie et al., 2000). Sidetracked/PlexinA3 deﬁnes
axonal exit points along the spinal cord and keeps CaP axons along
their deﬁned pathway (Palaisa and Granato 2007) whereas Topped
functions in the ventromedial fast muscle and is essential for motor
axon outgrowth into the ventral myotome (Rodino-Klapac and Beattie,
2004). However, there is still a paucity of cues identiﬁed that affect
motor axon outgrowth into speciﬁc myotome regions, Topped
functions in this capacity but the gene is not yet known (Rodino-
Klapac and Beattie 2004).
Semaphorins (Semas) are a large family of conserved axon
guidance ligands that are present in both vertebrates and inverte-
brates. They consist of eight classes that are either secreted or
membrane bound. Class 1 and 2 are present in invertebrates, classes
3–7 are present in vertebrates, and class 8 is found in DNA viruses
(Pasterkamp and Kolodkin, 2003; Semaphorin Nomenclature Com-
mittee, 1999). The receptors for these molecules are members of the
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al., 2000; He et al., 2002). The function of a number of semaphorins in
zebraﬁsh CaP axon guidance has already been elucidated using
reverse genetics in zebraﬁsh. Sema3A1 was identiﬁed as a repulsive
cue for CaP axons that delimits it to the initial commonpathway (Sato-
Maeda et al., 2006). It was found that CaP axons sensitivity to this
repulsive cue is dynamically regulated through expression of its
receptor Neuropilin 1A (Nrp1A) in the axon (Sato-Maeda et al., 2006;
Feldner et al., 2005) and that Plexin A3 is a possible co-receptor
(Feldner et al., 2007). Sema3AB was also implicated as an important
inhibitory cue in position ﬁne-tuning of CaP cell bodies which is
important in establishing proper exit points for CaP motor axons
(Sato-Maeda et al., 2008).
Sema5A is expressed in developing somites and limb buds in mouse
embryos and is widely expressed in mesodermal tissues (Adams et al.,
1996). In chick, Sema5A is expressed in the developing telencephalon
and heart (Jin et al., 2006; Pineda et al., 2005). Interestingly, inactivation
of Sema5A inmice results in embryonic lethality due to defects in blood
vessel stability in thedevelopingembryo suggestinga role for Sema5A in
vascular patterning (Fiore et al., 2005). Although more emphasis has
been placed on the semaphorins as inhibitory axon guidancemolecules
due to the presence of the inhibitory sema domain, they also have been
shown to have attractive capabilities (Wong et al., 1999; Artigiani et al.,
2004; Kantor et al., 2004). Sema1A was shown to function as an
attractive cue for developing peripheral neurons when added as a
soluble factor in the grasshopper limb bud (Wong et al., 1999). Sema5A
as well, was shown to act as not just an inhibitory cue but also an
attractive cueboth in culture and in the rat diencephalon as seen in brain
slices (Kantor et al., 2004).What makes vertebrate class 5 Semaphorins,
including Sema5A, unique is that they contain two clusters of type-1
thrombospondin repeats (TSR) 3′ to the sema domain (Adams et al.,
1996; Kantor et al., 2004). TSR domains have been shown to promote
axon outgrowth in in vitro studies (Neugebauer et al., 1991; O'Shea et al.,
1991; Osterhout et al., 1992; Rauvala et al., 2000; Kruger et al., 2004;
PasterkampandKolodkin, 2003; Kantor et al., 2004). The presence of an
inhibitory sema domain and a putatively attractive TSR domain in
class 5 molecules lends itself to the idea of Sema5A as a bifunctional
molecule (Kantor et al., 2004). Other bifunctional axon guidance
molecules have been identiﬁed namely, Netrin-1 and Sema3b (Seraﬁni
et al., 1996; Falk et al., 2005). In mouse, Netrin-1 functions to guide
spinal commissural axons to the ﬂoor plate where it is expressed
(Seraﬁni et al., 1996). At the same time, Netrin-1 acts as a repellant to
trochlear motor axons, steering it away from the ﬂoor plate
(Colamarino and Tessier-Lavigne 1995). Whether response to Netrin-
1 is attraction or repulsion of a growth cone is dictated by the
composition of netrin receptor complexes at the growth cone that
consists of DCC by itself or DCC in complex with UNC5 (reviewed by
Livesey, 1999, Manitt and Kennedy 2002). Sema3b was also found to
be a bifunctional cue in the mouse brain wherein it acts as an
attractant to neurons of the anterior pars of the anterior commisure
while it induces growth cone collapse in neurons of the posterior pars
of the anterior commisure (Falk et al., 2005). Both responses are
mediated by a receptor complex consisting of NrCAM and Nrp2 (Falk
et al., 2005). The difference in response is attributed to different
signaling cascades being activated by Sema3b in neurons of the
anterior pars versus neurons of the posterior pars (Falk et al., 2005).
Being a transmembrane semaphorin it is likely that Sema5A could
signal through plexin alone, without the requirement of a neuropilin
co-receptor unlike Sema3A1 (Negishi et al., 2005, Tamagnone et al.,
1999). Plexin B3 was previously identiﬁed as a putative Sema5A
receptor in COS cells (Artigiani et al., 2004), but no Plexin B3
homologue in zebraﬁsh has been identiﬁed. Plexin B3 was also not
detected in mice at the time-point at which Sema5A functions to
pattern the vasculature suggesting the presence of other Sema5A
functional receptors (Fiore et al., 2005). Plexin B1 belongs to the same
subfamily as Plexin B3 and has been shown to mediate Sema4Dinduced growth cone collapse in hippocampal neurons (Oinuma et al.,
2004). In Drosophila, Plexin Awas identiﬁed as a neuronal receptor for
the class 1 semaphorins Sema1a and Sema1b, which are transmem-
brane semaphorins (Winberg et al., 1998). As mentioned, Plexin A3
genetically interacts with Sema3A suggesting that it may be a
component of a receptor complex along with Neuropilin 1a. This
signaling is important for guidance of spinal primary motor axons as
well as for trigeminal and facial nerve axons (Feldner et al., 2007;
Palaisa and Granato, 2007; Tanaka et al., 2007).
Here we report that Sema5A acts as both a growth-promoting and
repulsive axon guidance cue for ventrally extending zebraﬁsh CaP
motor axons and is a unique cue as it speciﬁcally guides motor axons
into a speciﬁc myotome region. We demonstrate that this bifunction-
ality is mediated by the different functions of its two domains, the
sema domain and the TSR domain. We also show that Sema5A is a
potential ligand for Plexin A3 and that it contributes to specifying
axonal exit points in the spinal cord.
Materials and methods
Fish strains and maintenance
AB⁎ embryos, ABLF embryos, Tg(gata2:gfp) embryos, and Tg(islet:
gfp) embryos were used for morpholino and RNA injections and were
maintained between 25.5 and 28.5 °C. Embryos were staged by
converting the number of somites to hours post fertilization (hpf;
Kimmel et al., 1995).
Genomic cloning and sequencing
The zebraﬁsh semaphorin5A mRNA was predicted from the Sanger
Ensembl database (www.ensembl.org/Danio_rerio). The sema5A gene
was isolated by reverse transcription PCR (Qiagen One-Step RT-PCR
kit) using total RNA from 24 hpf pooled AB⁎ embryos. Gene speciﬁc
primers were designed based on the predicted mRNA coding
sequence. To determine the intron/exon boundaries, cDNA sequence
was aligned with the zebraﬁsh genomic database and proper
boundaries were deduced by comparing cDNA and genomic sequence.
RT-PCR products were cloned using the InvitrogenTopoTA Cloning kit.
Resulting colonies derived from AB⁎ were sequenced with either SP6
or T7 primers.
Morpholino analysis
For antisense oligonucleotide morpholino mediated knockdown of
Sema5A, two splice blocking morpholinos were designed to the splice
donor site of exon 3 (sema5A MO1: CTTCTTTACTTACACATTACTGGTG)
and splice donor site of exon 2 (sema5A MO2: CCTGAAGAGATGATTTC-
TAAAGGA). A translation blocking MO was also designed to an ATG-
containing sequence upstream of exon 1 sema5A translation blocking
MO (sema5A atg MO: GGTCCACGGGACACTGCTCAGTAC). 18 ng of MO
were injected into wild-type embryos and Tg(gata2:GFP) and Tg(islet1:
GFP) embryos at the one to two cell stage. Wild-type embryos were
allowed to develop to 26 hpf, and subsequently stained with znp1 or
used to isolate total RNA for RT-PCR analysis. Tg(gata2:GFP) and Tg(islet1:
GFP) injected embryos were allowed to develop to 48 and 72 hpf
respectively and motor axons were analyzed with a Zeiss axioplan
microscope. A control MO that does not have any known target in
zebraﬁsh was also used (ctl MO: CCTCTTACCTCAGTTACAATTTATA). To
test the efﬁciency of the splice blocking MOs, RT-PCR was performed
using the One-Step RT-PCR kit (Qiagen). sema5A transcript speciﬁc
primers ﬂanking the targeted MO site were used to amplify an 1100 bp
fragment in uninjected controls and an 850 bp fragment inMO injected
embryos. A different set of transcript speciﬁc primers were used to
conﬁrm splicing with sema5A MO2 to amplify a 250 bp fragment in
uninjected controls and an 100 bp fragment in MO2-injected embryos.
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plexin B1 were kindly provided by Sarah Childs (plexin B1-A MO:
TATTGGCTACTGTACCATGCAGGTC; plexin B1-B MO: TTCCAGCGG-
TAAGTTTGAAAACTAG). Both morpholinos were injected at 6 ng doses.
For sub-threshold co-injections 3 ng of sema5A, plexin B1-A, plexin B1-B
MOs and 1 ng of PlexinA3MOwere used. These doses were determined
by choosing the lowest dose MO tried that resulted in minimal
phenotypic defects that were not statistically different from wild-type
and control MO phenotypes (plexin A3 MO: ATACCAGCAGCCACAAG-
GACCTCAT) was kindly provided by Catherina Becker (Feldner et al.,
2007). Sub-threshold amounts of 1 ng plexin A3 and 3ng sema5A MO
were injected alone or together. Non-speciﬁc cell death, speciﬁcally in
the head, was observed in plexin A3 morphants. To resolve this we co-
injected 3ng p53 MO (GCGCCATTGCTTTGCAAGAATTG) (Robu et al.,
2007) with the plexin A3morpholino and the cell death was eliminated.
For all injections, embryoswere injected at the one to two cell stagewith
∼1 nl volume of solution as calculated bymeasuring injection bolus size
with a stage micrometer. All injected embryos were then allowed to
develop to 26 hours post fertilization (hpf) and stained with znp1
antibody.
RNA rescue and sema5A overexpression
For heterologous RNA rescue, the full-length rat sema5A gene
(Kantor et al., 2004) was cloned into the PCS2 vector. Two versions of
the sema5A gene the ﬁrst with the TSR domain attached to the
transmembrane domain (now referred to as TSR-TM) and the second
with the sema and transmembrane domains attached to the cartilage
oligomeric protein domain (now referred to as Semacomp) were also
cloned into the PCS2 vector (Kantor et al., 2004). Capped polyA mRNA
was transcribed using the mMessage mMachine (Ambion) SP6 kit and
injected at the one to two cell stage into wild-type zebraﬁsh embryos
at 500 pg doses with 18 ng of sema5A morpholino. 500 pg of the
generated sema5A RNA alone was also injected into one to two cell
stage embryos for Sema5A overexpression.Fig.1. sema5A is expressed in themyotome at 18 and 24 hpf. RNA in situ hybridization shows
Higher magniﬁcation views of trunk region of panels B and E. (G, H) 20 μm cross-sections o
myotome is outlined by dashed white line.Whole mount antibody labeling
Whole mount antibody labeling was performed as described in
Eisen et al., (1989) and Beattie et al., (2000). The znp1 monoclonal
antibody that recognizes primary and secondary motor axons
(Trevarrow et al., 1990; Melancon et al., 1997) was detected using
the Sternberger Clonal-PAP systemwith diaminobenzidine (DAB) as a
substrate (Beattie and Eisen, 1997). Znp1 recognizes synaptotagmin II
(Fox and Sanes 2007) and is a good antibody for visualizing early
developing motor axons. Embryos were analyzed with a Zeiss
axioplan microscope. CaP axons in segments 5-15 on both sides of
the embryo were analyzed.
Calculations and statistical analysis
Percentage of axons with observed phenotype (axon extension or
branching) were calculated from data combined from three different
experiments per treatment. Error bars for percentages were calculated
using conﬁdence interval for proportions at 95% conﬁdence with
sample size (n) being the total number of axons observed. Difference
in percentages was considered statistically signiﬁcant at 95% con-
ﬁdence. For rescue experiments one-way ANOVA was also performed
to determine p-values between 18 ng sema5AMO treatments and co-
injections of sema5AMO with either full length Sema5A rat RNA, TSR-
TM RNA or Semacomp RNA. Z-test for proportions was performed to
determine p-values for percentage of moderate and severely branched
axons and percent hemisegment with ectopic axonal exit points
between sema5AMO+plexin A3MO co-injections and single low-dose
MO injections of each.
Whole-mount in situ hybridization
Whole-mount RNA in situ hybridization was performed as
described by Thisse et al. (1993). An antisense digoxigenin zebraﬁsh
sema5A riboprobe was synthesized from a plasmid linearized withexpression of sema5A. (A, D, G) Sense and (B, E, H) anti-sense riboprobeswere used. (C, F)
f in situ labeled 24 hpf embryos. Spinal cord (sc) and notochord (nc) are indicated. The
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soaked in sterile 30% sucrose and then embedded in OCT at −80 °C
overnight and 20 micron sections were obtained. Sections were
analyzed with a Zeiss axioplan microscope.
Results
The Zebraﬁsh sema5A gene
The sema5A gene is annotated by Sanger Ensembl (www.ensembl.
org/Danio_rerio) and is located on linkage group 24. The gene
(Ensembl Gene ID: ENSDARG00000058821) spans 21 exons that covers
over 200 Kb. The predicted transcript (Ensembl Transcript ID: ENS-
DART00000081759) is 3480 kb and is predicted to encode for a 1046
amino acid protein. The domain structure of the predicted protein is
identical to that of other vertebrate species consisting of a sema
domain followed by seven type 1 and type 1-like TSR, a transmem-
brane domain and a short intracellular domain. An incomplete clone
containing exons 1 to 21 has been isolated and sequenced and was
used as basis for designing primers, riboprobes and morpholinos.
ClustalW analysis of sema5A transcripts from different vertebratesFig. 2. Morpholino knockdown of zebraﬁsh Sema5A results in delay in CaP axon extension
views of whole mount antibody labeling with znp1 of sema5AMO injected 26 hpf embryo (B
Arrowheads indicate delayed axons. Arrow indicate an aberrant branch (D) RT-PCR showin
MO-injected embryos compared to uninjected wild type embryos. (E) Axon position was sco
The landmarks on the x-axis are the horizontal myoseptum (HM), ventral edge of the noto
ventral muscle (DVM). (F) The axonal branching phenotype was scored by classifying bran
MO injected embryos (n=2020 axons, 101 embryos), sema5A MO and rat full-length sema5A
embryos) and control MO injected embryos (n=2360 axons, 118 embryos) with embryos
interval for proportions at 95% conﬁdence. Asterisks indicate signiﬁcant difference betw
embryos at pb0.001 using one-way ANOVA.shows that zebraﬁsh sema5A is more closely related to rat sema5A
with 79% homology. A zebraﬁsh homolog of the other vertebrate class
5 semaphorin Sema5B is located on chromosome 9. The predicted
mRNA is approximately 3000 bp in length and shares 46% identity
with sema5A, with a higher degree of homology in the sema domain
(74%) and the TSR domain (71%).
Zebraﬁsh sema5A is expressed in the ventral myotome
during development
Zebraﬁsh primary motor axons begin to extend out of the spinal
cord at 16–18 hpf, and complete their outgrowth along the medial
pathway by ∼24 hpf (Flanagan-Steet et al., 2005; Eisen et al., 1986,
Beattie 2000), thuswewould predict guidance cues functioning in this
process would be expressed during these time points. To examine the
expression pattern of sema5A in zebraﬁsh, we conducted RNA in situ
hybridization at 18 and 24 hpf. We generated anti-sense probes from
four, non-overlapping sema5A fragments. The sema5A transcript was
detected throughout the embryo at these time-points with slightly
stronger expression in the ventralmyotome for both time-points (Figs.
1B, C, E, F). Upon sectioning, however, expression was consistentlyand axonal branching and is rescued by full-length rat Sema5A mRNA. (A–C) Lateral
, C) and uninjected WT sibling (A). Dashed white line indicate ﬁrst intermediate target.
g efﬁcacy of sema5A splice site MO in inducing aberrant splicing of sema5A mRNA in
red using different landmarks along the axon pathway in a dorsal to ventral direction.
chord (VNC), proximal portion of the ventral muscle (PVM) and distal portion of the
ched axons into slight, moderate or severe branching. Data were quantiﬁed in sema5A
RNA co-injected embryos (n=2580, 129 embryos), WT uninjected (n=1640 axons, 89
obtained from at least three separate experiments. Error bars represent conﬁdence
een 18 ng sema5A MO-injected embryos and sema5a MO+rat sema5a RNA injected
Fig. 3. CaP axon branching. Examples of different extents of branching observed in
embryos (A) arrowhead indicates an axon with a slight branch characterized by short,
thin extensions from the main axon trunk. (B) Arrowhead indicates axon displaying
moderate branching characterized by either a longer extension from themain axon path
into the surrounding myotome or a slightly thicker extension (C) arrowhead indicates a
severely branched axon which is characterized by numerous and disordered branches.
Table 1
Summary of data from sema5A RNA rescue experiments
Genotype n (# of axons) % delayed axons % branched axons
sema5A MO-injected 2020 20%±1.7% 27%±1.9%
sema5A MO+FL Sema5A RNA 2580 5%±0.8% 11%±1.2%
sema5A MO+TSR-TM RNA 2300 6%±1.0% 22%±1.7%
sema5A MO+Semacomp RNA 2140 12%±1.4% 7%±1.1%
18 ng of sema5A MO and 500 pg of RNA were used in each experiment. n represents
total number of axons observed over three experiments. Percent delayed axons refer to
axons delayed at or before reaching the ventral edge of the notochord (VNC). Percent
branched axons refer to all classiﬁcations of observed branched axons. Conﬁdence
intervals calculated at 95% conﬁdence.
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diffused expression that was not higher in thesemyotome regions was
observed at later time points (36 hpf, 48 hpf, data not shown).
Presence of transcript was also detected by RT-PCR from as early as
18 hpf and as late as 48 hpf (data not shown). These data indicate that
Sema5A is present at the right time and place to function in guiding
axons as they pathﬁnd to the ventral myotome. We also looked at
expression of sema5b by RNA in situ hybridization and found that its
expression at these time-points does not overlap with sema5A
suggesting that they have divergent functions (see Supplementary
data, Fig. S1).
Knockdown of zebraﬁsh Sema5A causes delay in motor axon extension
into the ventral muscle and axonal branching defects
If Sema5A were involved in motor axon guidance, we would
predict that decreasing the levels of Sema5A would have an effect on
this process. To test this hypothesis, we employed splice-blocking
anti-sense morpholino oligonucleotides (MO). We designed a MO to
the splice donor site of sema5A exon 3 to preferentially result in the
excision of exon 4 causing a frameshift mutation in the Sema5A
protein. We injected 18 ng of the splice-site MO at the one to two cell
stage. To verify that the MO was knocking down Sema5A, we
conducted RT-PCR using total RNA obtained from both MO injected
embryos and uninjected wild-type siblings. Using gene speciﬁc
primers, we ampliﬁed an 1100 bp sema5A fragment in wild type and
an 850 bp sema5A fragment in MO injected embryos, consistent with
a loss of exon 4 that was conﬁrmed by sequencing (Fig. S2). In our
hands, we found the MO was successful in excising out exon 4
although we can still observe some full-length sema5A (Fig. 2D).
To observe the effect of Sema5A knockdown on axon outgrowth,
sema5A MO injected embryos (hereafter referred to as sema5A
morphants) were ﬁxed at 26 hpf and whole-mount antibody staining
was performed using the znp1 antibody. We analyzed 10 axons per
side (20 axons per embryo) and scored CaP axon growth cone positionas well as for other defects. At 26 hpf CaP axons have a stereotyped
morphology and project down into the either the proximal or the
distal portion of the ventral muscle (Fig. 2A). There was an overall
delay in the extension of the CaP axon into the ventral muscle in
sema5A morphants. 20% of hemisegments observed had growth
cones stalled at the horizontal myoseptum or near the ventral edge of
the notochord compared to only 1% stalled in uninjected embryos and
in control MO-injected embryos (Figs. 2B, E). In addition aberrant axon
branching was observed in 27% of the hemisegments observed in
morphants compared to only 10% observed in uninjected embryos and
9% in control MO injected embryos (Figs. 2C, F). Examples of branching
defects scored are shown in Fig. 3. Branching was characterized into
slight, moderate and severe branching phenotypes. Axons were
characterized as slightly branching with the observance of one or
more short ﬁne projections along the axon (Fig. 3A). Moderately
branched axons may have one to two slightly longer, thicker
projections (Fig. 3B). Severely branched axons were characterized as
having several long projections or exhibited aberrant patterns of
extension such as multiple (N2) branches, loops, early bifurcations, etc
(Fig. 3C). The same phenotypes were observed in 18 ng injections of
the translation-blocking morpholino although phenotypes were less
consistent and robust (Supplementary data) and knockdown of
protein levels could not be conﬁrmed due to the lack of an antibody,
therefore we used splice-blocking morpholinos for subsequent
experiments. To determine whether knock down of Sema5A affects
later-developing secondary spinal motor neurons, we injected the
same amount of sema5AMO into Tg(gata2:GFP) embryos and observed
motor axon outgrowth at 48 hpf. We observed no difference in
secondary motor axon morphology in sema5A morphants compared
to control MO-injected and uninjected embryos. The dorsally
projecting motor nerves were also largely normal at 72 hpf as
observed in Tg(islet1:GFP) embryos. These results suggest that
Sema5A function in motor axon guidance is important during axon
outgrowth early in development.
RNA rescue of morpholino phenotype
To ensure that the sema5A knockdown was speciﬁc, we rescued
the CaP axon phenotype with rat sema5A RNA (Kantor et al., 2004).
We generated capped polyA sema5A RNA from cDNA clones and co-
injected 500 pg of RNA with 18 ng sema5A MO at the single cell
stage. It is important to note that the MO was designed to recognize
zebraﬁsh sema5A mRNA but not rat sema5A mRNA. At 26 hpf, we
processed embryos for whole-mount antibody labeling. Ten ventrally
extending CaP axons per side in the mid-trunk section (20 axons per
embryo) were scored for growth cone position and other defects.
Over expression of full-length rat sema5A RNA alone showed no
aberrant phenotype (data not shown). When sema5A MO was co-
injected with full-length rat Sema5A RNA, however, there was a
signiﬁcant decrease in the percentage of motor axons that were
delayed before reaching the ventral muscle with 5% delayed
compared to 20% delayed in embryos injected with MO alone at
26 hpf (Fig. 2E, Table 1). This corresponds to a four-fold increase in
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and RNA co-injected embryos compared to MO injected alone. There
was also a signiﬁcant decrease in the percentage of branched axons
with 11% of motor axons branched in embryos co-injected with MO
and rat mRNA compared with 27% in embryos injected with MO
alone (Fig. 2F, Table 1). This suggests that full-length rat Sema5A RNA
is able to signiﬁcantly rescue the aberrant phenotypes in sema5A
morphants.
Sema5A and known zebraﬁsh plexins
We next asked whether any of the known zebraﬁsh Plexins were
receptors for Sema5A. There are two isoforms of plexin B1 identiﬁed
in zebraﬁsh by a Blast search and these two have been arbitrarily
named plexin B1-A and plexin B1-B (Sarah Childs, personal commu-
nication). plexin B1-A is located on chromosome 23 and plexin B1-B is
located on chromosome 6. Reduction of Plexin B1-A by a splice
blocking MO resulted in an increase in slight to severe branching of
CaP axons while reduction of Plexin B1-B resulted in delay in CaP
axon extension (Figs. 4A, C). To determine whether any of these
plexins may be a receptor for Sema5A we performed co-injections of
MOs against Sema5A and Plexin B1-A or Plexin B1-B at low doses as
well as injections of each MO at low dose by itself. There was noFig. 4. plexin B1-A and plexin B1-B morpholino injection phenotypes and co-injections with
compared to control MO injected embryos. (B) Co-injection of 3 ng plexin B1-AMO and sema
6 ng plexin B1-BMO results in a delay in CaP axon extension into the ventral myotome compa
MO displayed no delay of CaP axon extension phenotype. Data quantiﬁed from 3 ng sema
embryos (n=1040 axons, 52 embryos), 3 ng plexin B1-A MO injected embryos (n=940 axons
107 embryos), 6 ng plxnB1B MO injected embryos (n=1960 axons, 98 embryos), 3 ng plexin
B1-BMO injected embryos (n=1180 axons, 59 embryos). Error bars represent conﬁdence inte
control MO injected and plexin B1-A or plexin B1-B MO injected with pb0.001 using one-wsynergistic increase in either of the two phenotypes observed in both
co-injections (Figs. 4B, D), which suggests that though Plexin B1-A
and Plexin B1-B may be acting on CaP axon guidance, Sema5A is not
the speciﬁc ligand for these plexins.
Genetic mutation in the plexin A3 gene, as well as morpholino
knockdown exhibits aberrations in motor axon outgrowth (Feldner et
al. 2007; Palaisa and Granato 2007). The two phenotypes observed are
branching of CaP axons and axons exiting the spinal cord at ectopic
exit points (Birely et al., 2005; Feldner et al., 2007; Palaisa and
Granato, 2007). Since the branching defects caused by both Plexin A3
and Sema5A knockdown were similar, we asked whether Plexin A3
might be mediating Sema5A function in primary motor axon
guidance. Therefore we performed sub-threshold co-injections of se-
ma5AMO and plexin A3MO and individual low dose injections of each
MO. Embryos were injected with 1 ng plexin A3 MO, which is 1/9 of
the optimal dose used by Feldner et al. (2007). At this dose we
observed that 9% of CaP axons were moderately to severely branched.
The branching phenotypes observed are identical to what we observe
with Sema5A knockdown (Fig. 5A). Injection of sema5A MO at 3 ng, a
much lower dose than our optimal dose which is 18 ng, caused
moderate and severe branching in 6% of CaP axons observed. Injecting
3 ng sema5A MO and 1 ng plexin A3 MO together resulted in 16%
moderately and severely branching axons which is roughly the sum ofsema5A. (A) Injection of 6 ng plexin B1-A MO shows an increase in branching CaP axons
5AMO has little or no difference with injection of each MO by itself at 3 ng. (C) Injection
red control MO injected embryos. (D) Co-injection of 3 ng of plexin B1-BMO and sema5A
5A MO injected embryos (n=2020 axons, 101 embryos), 6 ng plexin B1-A MO injected
, 47 embryos), 3 ng sema5AMO+3 ng plexin B1-A MO injected embryos (n=2140 axons,
B1-B MO injected embryos (n=1080 axons, 54 embryos), 3 ng sema5A MO+3 ng plexin
rval for proportions at 95% conﬁdence. Asterisks indicate signiﬁcant difference between
ay ANOVA.
Fig. 5. Additive and synergistic interactions of Sema5A and Plexin A3. (A) Axonal phenotypes observed in embryos injected with plexin A3MO alone or plexin A3MO and sema5AMO.
Arrows indicate moderately and severely branched CaP axons, arrowheads indicate axons exiting the spinal cord at ectopic exit points. (B) Percentage of axons with moderate and
severe branching in embryos injected with 3 ng of sema5A MO alone, 1 ng of plexin A3 MO alone and a combination of 3 ng sema5A MO and 1 ng plexin A3 MO. (C) Percentage of
hemisegments observed with ectopic axonal exit points in embryos injected with 3 ng sema5AMO, 1 ng plexin A3MO and a combination of 3 ng sema5A MO and 1 ng plexin A3MO.
Data quantiﬁed from 3 ng sema5A MO injections (n=860 axons, 43 embryos), 1 ng plexin A3 MO injection (n=2860 axons, 140 embryos) and 3 ng sema5A MO+1ng plexin A3 MO
injections (n=2760 axons,128 embryos). Ectopic axonal exit points were not observed in bothwild-type uninjected or control MO-injected embryos (not shown). Error bars represent
conﬁdence interval for proportions at 95% conﬁdence. Asterisks indicate signiﬁcant difference between sema5A MO+plexinA3 MO injected and both 3 ng sema5A MO injected and
plexinA3 MO injected at pb0.01 using a Z-test of proportions.
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itself at 3 ng, indicating that the effect of decreasing Sema5A and
Plexin A3 is roughly additive. In addition to the branching phenotype
we observed axons coming out of ectopic exit points along the spinal
cord as was observed by Feldner et al. (2007) and Tanaka et al. (2007)
in plexin A3morphants and by Birely et al. (2005) in sidetracked/Plexin
A3 mutants (Fig. 5A). This phenotype is not observed in uninjected
wild type embryos and control MO injected embryos. We counted the
number of axons exiting from ectopic exit points within the ten trunk
hemisegments per side that we use for quantiﬁcation and saw 5% of
hemisegments had ectopic axons in embryos injected with 1 ng Plexin
A3MO. In low dose sema5AMO and plexin A3MO co-injected embryos
we observed 17% of hemisegments had ectopic axons. This value is
comparable with what was observed in sidetracked/Plexin A3 genetic
mutants where ectopic axons were observed in 5–23% of total
hemisegments (Birely et al., 2005). Since ectopic exit points are not
seen in the optimal dose (18 ng) nor in the lowdose (3 ng) injections of
sema5A MO we repeated this co-injection experiment using a second
splice-site MO against Sema5A (sema5a MO2) designed to splice out
exon 3. Splicing was conﬁrmed by RT-PCR (data not shown). An 18 ng
dose of sema5A MO2 induces ectopic axonal exit points in 6/2140
hemisegments observed which is about 0.3% incidence. Ectopic axonal
exits were not observedwith 3 ng dose of sema5AMO2. Co-injection of
3 ng sema5A MO2 with 1 ng plexinA3 MO induces ectopic axon exit
points in 14% hemisegments observed (Supplementary Fig. 5). This
is consistent with what we observe with the ﬁrst sema5A MO whenco-injected with the plexinA3 MO and conﬁrms Sema5A's role in this
process. Taken together, these data suggest that although Sema5A and
Plexin A3 do not work together to guide motor axons into the ventral
myotome, they do appear to interact to specify spinal cord exit points.
Whether this interaction occurs directly as a ligand–receptor pair or
indirectly as in they function in the same or parallel pathways has yet
to be determined.
The TSR domain of rat sema5A rescues delay of CaP axon extension in
sema5A morphants
It was previously shown that Sema5A may act as a bifunctional
axon guidance cue via the function of its two domains, the TSR domain
and the sema domain (Kantor et al. 2004). To determine whether it
functions as such in motor axon guidance in vivo, we used constructs
that contain the different functional domains of rat Sema5A. The TSR
domain is believed to be an attractive cue in axon guidance. We
generated capped poly A RNA encoding for Sema5A TSR domain
attached to a transmembrane domain (TSR-TM) from cDNA clones
(Kantor et al., 2004). Injection of TSR-TM RNA by itself does not induce
any motor axon defects (data not shown). We then co-injected this
RNA with sema5A MO at the one to two cell stage and subsequently
ﬁxed and stained the embryos at 26 hpf. As in the full-length RNA
rescue experiment, there was an observed decrease in percentage of
axons that were delayed before reaching the ventral muscle, with 6%
of axons delayed in sema5AMO and TSR-TM RNA co-injected embryos
Fig. 6. Rescue of sema5A morphant embryos with rat Sema5A TSR domain and rat Sema5A sema domain. Growth cone position (A, C) and extent of branching (B, D) were scored in
sema5A MO-injected embryos (MO-injected), sema5A MO and rat TSR domain RNA co-injected embryos (MO+TSP-TM; A, B), sema5A MO and rat sema domain RNA co-injected
embryos (MO+Semacomp; C, D) and uninjected embryos (WT uninjected). Data were quantiﬁed in sema5AMO injected embryos (n=2020 axons, 101 embryos), sema5AMO and TSR-
TM RNA co-injected embryos (n=2300 axons, 115 embryos), sema5A MO and Semacomp RNA co-injected embryos (n=2140 axons, 107 embryos), WT uninjected (n=1640 axons, 89
embryos) and control MO injected (n=2360 axons, 118 embryos). Error bars represent conﬁdence interval for proportions at 95% conﬁdence. Asterisks indicate signiﬁcant difference
between sema5A MO injected and sema5AMO+TSR-TM RNA injected or sema5A MO+ semacomp RNA injected embryos with signiﬁcance of pb0.001 using one-way ANOVA.
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However there was no signiﬁcant difference in the percentage of
axons exhibiting slight andmoderate axonal branching in embryos co-
injected with sema5A MO and TSR-TM RNA compared to embryos
injected with MO alone (Fig. 6B). This suggests that the TSR domain of
Sema5A inﬂuences CaP axon growth cone migration towards the
ventral muscle, but that it does not function to keep CaP axons on their
deﬁned pathway.
The sema domain of rat Sema5A rescues axonal branching defects in
sema5A morphants
The sema domain has been shown to mediate the inhibitory effect
of semaphorins (Klostermann et al., 1998; Kantor et al., 2004). To
determine whether the sema domain is important for CaP axon
guidance, wemade capped poly A RNA from cDNA clones encoding for
the sema domain attached to a transmembrane domain and a COMP
domain (Semacomp RNA). The COMP domain is key to oligomerization
of sema proteins, which is important for its function (Kantor et al.,
2004). We then co-injected the Semacomp RNA with sema5AMO into
one to two cell stage embryos followed by analysis of motor axons at
26 hpf. There was a signiﬁcant decrease in axons stalled at or before
reaching the ventral edge of the notochord from 20% in MO-injected
embryos to 12% of axons in embryos co-injected with sema5AMO and
Semacomp RNA (Fig. 6C, Table 1). However, this number is still
signiﬁcantly higher than observed delayed axons in full length rat
sema5A RNA rescued embryos (5%) or in TSR-TM RNA rescued
embryos (6%) suggesting that the sema domain only partially rescuesthis phenotype. There was, however, a signiﬁcant decrease in the
percentage of axons exhibiting aberrant branching in embryos co-
injected with sema5A MO and Semacomp RNA (6%) compared to se-
ma5A morphants (27%) (Fig. 6D). This ﬁnding suggests that the sema
domain of Sema5A functions to delimit the axons to their pathway as
they migrate towards the ventral muscle. Taken together these RNA
add-back experiments reveal that the TSR domain of Sema5A acts in a
positive manner to guide axons into the ventral myotomewhereas the
sema domain acts primarily in a negative manner to prevent axon
branching and keeps axons extending along a deﬁned pathway.
Discussion
The stereotyped outgrowth of ventral axial motor axons is
dependent upon the presentation and proper integration of the
appropriate guidance cues in the ventral myotome. Our under-
standing of the cues guiding zebraﬁsh primary motor axons from
the spinal cord towards its target has increased in recent years,
particularly with cues that govern outgrowth from the spinal cord as
well as cues that guide the axons in the common pathway and up to
the ﬁrst intermediate target. However, cues that speciﬁcally guide
axons toward their ﬁnal target, the ventral myotome have yet to be
determined. By morpholino knockdown of Sema5A, we demonstrate
that the Sema5A ligand is a critical cue that guides CaP motor axons
into the ventral muscle by its ability to act as a bifunctional axon
guidance cue. In addition to promoting axon outgrowth to the ventral
muscle, Sema5A also appears to be acting as a repulsive cue in the
environment, preventing growth cones frommigrating away from the
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this dual function occurs via the two different domains of Sema5A, the
TSR domain and the sema domain. Our data conﬁrms the bifunction-
ality of Sema5A as a consequence of the different functions of its two
domains and demonstrates the role of Sema5A in the motor axon
system in an in vivo model. Our data also reveal a genetic interaction
between Sema5A and Plexin A3 relevant to ventral root formation. It is
possible that Sema5A and Plexin A3 interact to prevent ectopic ventral
root formation, however a direct interaction between these two
proteins has not yet been established.
Sema5A is a bifunctional axon guidance cue for CaP axons
Kantor et al. (2004) showed that Sema5A acts as a bifunctional
axon guidance cue in the diencephalic axon tract, the fasciculus
retroﬂexus, which originates from the habenula nucleus and extends
between prosomere 1 and 2 without crossing into either prosomere.
Sema3F has been implicated as the repulsive cue in prosomere 1
(Funato et al., 2000; Sahay et al., 2003). Sema5A expression was
detected in prosomere 2 as well as in the habenular neuron cell body.
Their ﬁndings suggest that Sema5A acts as both an attractive cue in
the axons themselves, causing the axons to remain fasciculated, and
as a repellant in prosomere 2 that prevents axons from crossing into
that region. In zebraﬁsh, we did not observe Sema5A expression in
motoneurons, which tells us that both attractive and repulsive effects
of Sema5A are being mediated in the environment. Sema5A may be
acting as a repulsive cue in the environment surrounding the CaP
axon pathway and by knocking down Sema5A levels the surrounding
area becomes permissive for the migrating growth cones. This
phenotype may be comparable to the observation in organotypic
diencephalon explants treated with antibodies against Sema5A
wherein axon tracts extended into prosomeres 1 and 2 and were
no longer restricted to the boundary between the prosomeres; and
often do not reach their targets (Kantor et al., 2004). Sema5A was
demonstrated previously to also have the ability to be an attractive
cue to habenular neurons in an in vitro stripe membrane assay
(Kantor et al., 2004). We show here in vivo that Sema5A is acting as a
cue that promotes extension of motor axon growth cones into the
ventral muscle. Knocking down Sema5A causes a delay in extension
of CaP axon growth cone into the ventral muscle, suggesting that
Sema5A normally functions to guide axons into the ventral muscle.
That the delay is transient and not permanent in our morphants
suggests that there could be other cues acting on growth cones or
that since we do not have a complete absence of Sema5A, the growth
cones are merely slowed down by the low levels of Sema5A. Sema5A
inactivation in mice results in embryonic lethality due to vascular
instability (Fiore et al., 2005). The embryonic nervous system was
largely normal in the knockout mouse although the possibility that
subtle defects in a small subset of axons was not dismissed by the
authors (Fiore et al., 2005).
Although semaphorins are largely considered inhibitory cues,
another transmembrane semaphorin, Sema1A has also been shown to
function as an attractive cue for developing peripheral neurons in the
grasshopper limp bud (Wong et al., 1999). Sema1A only has the sema
domain so it is believed that a downstream signaling receptor/s is
responsible for its attractive function (Wong et al., 1999). For Sema5A
however, the presence of the type-1 TSR domain was shown to be
responsible for its ability to be both an attractive and a repulsive cue to
rat habenular neurons (Kantor et al., 2004). TSRs are known to interact
with different sulfated proteoglycans in the extracellular matrix and it
was demonstrated that the presence of chondroitin sulfate proteogly-
can (CSPG) versus heparan sulfate proteoglycan (HSPG) switches
Sema5A from an inhibitory cue to an attractive one (Kantor et al.,
2004). The TSR domain in F-spondin also conveys attractive function
to this protein and functions to guide commissural axons to the ﬂoor
plate in mouse (Burstyn-Cohen et al., 1999).By analyzing the sema and TSR domains separately, we show that
the bifunctionality of Sema5A corresponds to the different functions of
these two domains. That the TSR domain alone rescues the delay
phenotype of CaP axon growth cones in sema5A morphants but not
the branching phenotype suggests that this domain is important
speciﬁcally for promoting extension of CaP axons into the ventral
muscle. On the other hand, the sema domain alone rescues the
branching phenotype in sema5A morphants as well as the delay
phenotype, though the latter is rescued to a much lesser extent. This
suggests that the sema domain is acting as a repulsive guidance cue in
the environment and serves to delimit CaP axons to their pathway. The
slight rescue of the delay phenotype by the sema domain could be
attributed to the ability of this cue to guide the growth cone at earlier
choice points possibly the horizontal myoseptum. It was previously
shown that in embryos where expression of the repulsive semaphorin
Sema3a1 was knocked down by morpholinos, there was an observed
delay of the CaP axon growth cones as it extends through the
horizontal myoseptum (Sato-Maeda et al., 2005). This suggests that
the adding back of a repulsive cue, the sema domain in our case, could
possibly prevent prolonged pausing at this intermediate target and
promote extension into the ventral muscle. Our data agree with data
from habenular neuron cultures where stripes that expressed the TSR-
TM protein where permissive for axon growth whereas the stripes
that expressed the Semacomp proteinwere repulsive to axons (Kantor
et al., 2004).
Interestingly, no axon defects were observed with over expression
of full-length Sema5A, TSR-TM RNA or sema domain alone by RNA
injection (data not shown). This could possibly be due to a strict
regulation of receptors expressed in the motor axon, that is, over
expression of a ligand should not have an effect if there are limited
amounts of receptors that could detect it. Tight regulation of receptors
expressed by the CaP axons has been observed with Neuropilin1a
(Npn1a) wherein npn1a is expressed in the cell body of the CaP axon
while the axon traverses the common pathway (before reaching the
horizontal myoseptum) and is then down regulated once the axon has
passed the horizontal myoseptum (Sato-Maeda et al., 2005). It is also
possible that for the TSR-TM domain to act as an attractant, it requires
interaction with other factors that are speciﬁcally present in the
ventromedial muscle. Analysis of the Toppedmutant supports such an
idea. In these mutants it was shown that when adding back wild type
cells to Topped mutants, motor axons were able to extend normally
only when wild type cells were in the medial most portion of the
ventral muscle but not when they were even one cell body more
lateral (Rodino-Klapac and Beattie 2004). These data suggest that the
ventromedial muscle cells may contain the complement of proteins
necessary to support motor axons as they leave the spinal cord and
extend ventrally. It is also likely that the more lateral fast muscle cells
express inhibitory cues that cannot be overcome by other cues. This is
supported by the ﬁnding that knocking down Sema3a1 causes CaP
axons to extend laterally at least along the initial common pathway
(Sateo-Mato et al., 2005). The fact that CaP axons extend ventrome-
dially even though endogenous Sema5A is diffusely expressed in the
myotome indicates that its function in promoting axon outgrowth is
speciﬁcally regulated in medial fast muscle cells. Thus, data support
that CaP axon outgrowth, at least during this early phase, is tightly
regulated and may depend on both growth promoting and repulsive
cues.
Plexin A3: a Sema5A receptor?
Transmembrane semaphorins such as Sema5A are believed to have
the ability to signal through plexin receptors by themselves, without
the requirement of neuropilin co-receptors. Therefore, investigating
potential interactions of Sema5A with plexins is a way to begin to
deﬁne the Sema5A receptor. Plexin A3 and Plexin B1 have both been
identiﬁed as important receptors for mediating repulsive semaphorin
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Plexin B1 (Feldner et al., 2007; Ito et al., 2006). We have shown that
although knockdown of two isoforms of Plexin B1 affect CaP axon
outgrowth, Sema5A does not appear to be involved. It was previously
shown that Plexin A3 knockdown, both by mutation and by
morpholino yields ectopic exit points as well as CaP axon branching,
the latter being similar to that observed in Sema5A morphants
(Feldner et al., 2007; Palaisa and Granato, 2007). That subthreshold
co-injections of plexinA3 MO and sema5A MO shows a robust
synergistic (with synergism being deﬁned as greater than simply
additive) effect on the ectopic exit point phenotype compared to each
morpholino on its own, suggests that Sema5A could be a repulsive
axon guidance cue that acts through the Plexin A3 receptor. It was
shown through similar means that both Sema3A1 and Sema3A2 act
synergistically with Plexin A3 to induce ectopic exit points (Feldner et
al., 2007). This suggests that multiple repulsive cues may be
responsible for deﬁning exit points along the spinal cord. Sema3A1
and Sema3A2 both have speciﬁc expression patterns in each somite
during development (Shoji et al., 2003; Sato-Maeda et al., 2006;
Feldner et al., 2007) whereas Sema5A is diffusedly expressed
throughout the developing trunk including the myotome region
near the spinal cord ventral roots. Since knocking down Sema5A by
itself induced only a slight increase in ectopic axonal exit points (as
seen with the use of Sema5A MO2, Supplementary Fig. 5), it indicates
that other repulsive cues, most likely these other inhibitory
semaphorins, are able to compensate for the knockdown of Sema5A.
It was not determined though whether Sema5A and Plexin A3 directly
bind. However, it has been shown that Plexin A1 which belongs to the
same plexin subfamily as Plexin A3 directly binds a transmembrane
semaphorin Sema 6D without the requirement of a neuropilin co-
receptor (Tamagnone et al., 1999; Toyofuku et al., 2004a,b). This
indicates that Sema5A, which is also transmembrane, could bind
Plexin A3 directly. The role of Sema5A in CaP axon branching and
extension into the myotome does not appear to be mediated through
Plexin A3. This suggests the existence of a yet unidentiﬁed Sema5A
receptor/s that is present in the CaP motoneurons. In the study
mentioned above, Sema6D was also found to bind another plexin
receptor, Plexin A4, although weakly (Toyofuku et al., 2004a,b). This
indicates that semaphorins can bind more than one plexin receptor
supporting the possibility that Sema5A could bind to different plexins
that mediates different functions such as exit point recognition and
axon outgrowth along the myotome.
Sema5A may be modulated by proteoglycans in vivo
How is Sema5A being recognized as a bifunctional cue? It is
possible that in a particular environmental context, it is repulsive due
to its sema domain but in another context it is growth promoting due
to its TSR domain. This idea is supported by in vitro ﬁndings that in the
presence of CSPGs, Sema5A acts as an inhibitory molecule but
mediates attraction in the presence of HSPGs (Kantor et al., 2004).
Therefore, interaction of Sema5A with these two proteoglycans may
be a mechanism through which the function of Sema5A is dictated.
This interaction is believed to occur between the glycosaminoglycan
portions of the sulfated proteoglycans and the TSR domain of Sema5A
(Adams and Tucker 2000). CSPG expression has been detected along
the ventral portion of the motor axon pathway during the period of
primary motor axon pathﬁnding (Zhang et al., 2004) placing it in the
right time and location to possibly interact with Sema5A. However,
knock down of Chondroitin synthase I, an enzyme involved in CSPG
synthesis, resulted in a decrease in immunoreactivity of CSPs but did
not cause motor axon defects in zebraﬁsh (Zhang et al., 2004) nor did
low dose double knock down of Sema5A and CSPG result in axon
defects (JDH and CEB unpublished data). One possible caveat from
these studies is that the antibody used recognized type A and C, but
not type B Chondroitin Sulfate (Avnur and Geiger, 1984) so it is unclearif this type B form was also reduced. HSPGs are also expressed
diffusedly throughout the developing zebraﬁsh embryo (Chen et al.,
2005) and mutations in key enzymes in HSPG synthesis result in
defects in both muscle and vascular development (Bink et al., 2003;
Chen et al., 2005). In addition, knocking down the HSPGAgrin resulted
in primary motor axon truncations and branching in addition to other
morphological phenotypes (Kim et al., 2007). Another component of
the extracellularmatrix, Tenascin-C, was previously shown to function
in CaP axon guidance (Schweitzer et al., 2005). This demonstrates that
the extracellular matrix may be a rich source of guidance cues for the
migrating growth cone and that understanding interactions of ECM
components with guidance molecules is important to fully under-
stand the mechanisms that underlie axon guidance.
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